The global narcolepsy therapeutics market size was estimated at USD 1,305.2 million in the year 2016 and to Reach US$ 6047.3 Mn by 2025, due to the Growing Awareness about Sleep Disorder.
Narcolepsy is a therapeutic disorder which is categorized by prodigious daytime sleepiness as well as sudden attacks of sleep. In some cases, this chronic sleep disease can lead to an abrupt loss of muscle tone (cataplexy), leading to loss and weakness of muscle control. Some of the most common indications of narcolepsy are daytime sleepiness, hallucinations, fragmented sleep & insomnia, and sleep paralysis.
The Narcolepsy Therapeutics Market report covers all the minute details related to the industry like technological developments, growth opportunities, threats to market growth, innovative strategies and futuristic market trends. The report provides a basic overview of the industry including definitions and classifications. The market analysis is provided for the international markets including development trends, competitive land scape analysis, and key regions development status.
The increasing prevalence of sleeping disorders, sleeping paralysis and cataplexy among the humans has surged the significance of therapeutic measures for the disorder. Narcolepsy is caused owing to the loss of hypocretin cells. The hypocretin cells comprises of neurotransmitters that are involved in the regulation of wake/sleep and other body functions such as metabolism and blood pressure. Hence, various health and medical centers are undergoing continuous research, set of medical tests, sleep study and multiple sleep latency tests to diagnose the sleeping disorder.
According to Narcolepsy Network, only 25% of people suffering from the condition are estimated as diagnosed worldwide. This disease is comparatively difficult to diagnose due to low awareness amongst patients & healthcare providers. The favorable reimbursement policies associated with the drugs are further fueling the growth of this vertical.
Some major key players in global Narcolepsy Therapeutics Market include Addrenex Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., BIOPROJET, Cephalon, Inc., Evotec AG, Graymark Healthcare, Inc., Hypnion, Inc., Jazz Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd. among others.
Global market analyses the report based on customer demand, supply and demand status, competitive market scenario and industry policies. The company profile of the eminent Narcolepsy Therapeutics market players based on the sales margin, import/export scenario, past, present and the future market scenario will filter essential market details.
Based on Type the market is segmented into Narcolepsy With Cataplexy, Secondary Narcolepsy and Narcolepsy Without Cataplexy. The section Narcolepsy With Cataplexy is leading the global market due to rising cases of cataplexy which is the primary symptom seen in patients.
Based on Product the market is segmented into Tricyclic Antidepressants, Central Nervous System Stimulants, Selective Serotonin Reuptake Inhibitor, Sodium Oxybate and Other Products. The Sodium Oxybate sections is dominating the global market due to rising cost of the drugs, increasing awareness amongst the people for the diagnosis & treatments, presence of refunding policies, etc.
Trending tweet for more information:
Global Narcolepsy Therapeutics Market Estimated to Reach US$ 6047.3 Mn by 2022, due to the Growing Awareness about Sleep Disorder.
For more information of report : https://t.co/wpEa78B30j
— MarketInsightsReport (@MIRresearch) July 16, 2019
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687